We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

49 hedge funds and large institutions have $9.37M invested in Fortress Biotech in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 49 → 49 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

1.23% less ownership

Funds ownership: 10.71% → 9.47% (-1.2%)

14% less capital inflows, than outflows

Capital inflows: $4.17M | Capital outflows: $4.85M

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
12
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.44M
2
Millennium Management
Millennium Management
New York
+$1.24M
3
Paloma Partners
Paloma Partners
Connecticut
+$281K
4
FNY Investment Advisers
FNY Investment Advisers
New York
+$231K
5
Jane Street
Jane Street
New York
+$226K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.44M
2
State Street
State Street
Massachusetts
-$823K
3
STRS Ohio
STRS Ohio
Ohio
-$476K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$243K
5
Charles Schwab
Charles Schwab
California
-$135K

FBIO Hedge Fund Activity: Q2 2019 in Review

49 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2019, worth a combined $9.37M — down 21% from $11.9M a quarter earlier.

Fund positioning in FBIO was balanced in Q2 2019: 15 funds opened new positions, 15 closed out, 7 added to existing stakes and 12 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.44M. The largest seller was BlackRock, cutting an estimated $2.44M.

  • 49 institutional investors held Fortress Biotech (FBIO) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $9.37M of Fortress Biotech stock for Q2 2019, down 21% quarter-over-quarter.
  • 15 funds opened new Fortress Biotech positions in Q2 2019 and 15 closed out, a net change of 0 holders.
  • The largest Fortress Biotech buyer in Q2 2019 was Vanguard Group, an estimated $1.44M added.
  • The largest Fortress Biotech seller in Q2 2019 was BlackRock, an estimated $2.44M sold.

Based on aggregated 13F filings for Q2 2019.